Apellis Pharmaceuticals, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Fifth Avenue, Waltham, MA

Insiders trading volume in the past year

Apellis Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $816M Nov 18, 2021
Cedric Francois Chief Executive Officer, Director $51.7M -$10.4M -16.8% Aug 27, 2025
Alec Machiels Director $11.3M Jan 1, 2025
Timothy Sullivan Chief Financial Officer $10.4M -$1.41M -12% Sep 8, 2025
Lukas Scheibler Chief Research Officer $6.96M Dec 1, 2023
David Watson General Counsel $6.17M -$1.62M -20.8% Sep 16, 2025
Federico Grossi Chief Medical Officer $6.04M Jan 5, 2023
Pascal Deschatelets Chief Scientific Officer $5.96M -$233K -3.75% Jun 9, 2025
Sinclair Dunlop Director $4.79M -$1.42M -22.8% Sep 30, 2025
Caroline Baumal Chief Medical Officer $4.39M -$151K -3.32% Jun 9, 2025
Nur Nicholson Chief Technical Officer $4.07M -$284K -6.53% Jun 9, 2025
Kelley Boucher Chief People Officer $4.03M Sep 2, 2025
Mark DeLong Chief Business & Strat Officer $4M -$147K -3.54% Jun 9, 2025
Victoria Brown Program Team Lead $3.14M Jan 20, 2023
Adam Townsend Chief Commercial Officer $2.48M -$265K -9.64% Jan 29, 2025
Karen Lewis Chief People Officer $2.07M -$147K -6.62% Jan 29, 2025
Leslie Meltzer Chief Research and Development $1.73M Aug 26, 2025
James Chopas VP/Chief Accounting Officer $1.72M -$102K -5.57% Sep 15, 2025
Jeffrey Eisele Chief Development Officer $1.63M -$57.1K -3.38% Jan 29, 2025
Craig A. Wheeler Director $874K Apr 17, 2025
Keli Walbert Director $815K Jan 8, 2025
Nicole Perry Vice President - Accounting $717K Aug 2, 2021
Paul R. Fonteyne Director $696K Jan 1, 2025
Gerald Chan Director $626K Jan 1, 2025
Stephanie O'Brien Director $626K Jan 1, 2025

Recent Insider Transactions by Companies or Individuals for Apellis Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.